| |
| |
|
| Insider
Information: |
Payne John Bernard |
| Relationship: |
|
| City: |
Vancouver |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
9,401 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
9,401 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nexvet Biopharma Plc |
NVET |
Director |
2017-07-31 |
0 |
2017-07-31 |
0 |
Premium* |
|
|
Zivo Bioscience, Inc. |
ZIVO |
|
2022-12-19 |
9,401 |
2020-09-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZIVO |
Zivo Bioscience, Inc. |
President and CEO |
• • – |
2022-12-19 |
4 |
B |
$2.50 |
$143 |
D/D |
57 |
9,401 |
0.01 |
- |
|
| ZIVO |
Zivo Bioscience, Inc. |
|
• • – |
2022-01-27 |
4 |
B |
$2.50 |
$115 |
D/D |
46 |
9,344 |
0.01 |
- |
|
| ZIVO |
Zivo Bioscience, Inc. |
|
• • – |
2022-01-25 |
4 |
B |
$2.50 |
$22,805 |
D/D |
9,122 |
9,298 |
0.01 |
- |
|
| ZIVO |
Zivo Bioscience, Inc. |
Director |
– • – |
2020-09-09 |
4 |
D |
$0.11 |
$25,943 |
D/D |
(235,849) |
14,151 |
0 |
- |
|
| ZIVO |
Zivo Bioscience, Inc. |
Director |
– • – |
2020-09-09 |
4 |
OE |
$0.10 |
$25,000 |
D/D |
250,000 |
250,000 |
0 |
- |
|
| NVET |
Nexvet Biopharma Plc |
Director |
– • – |
2017-07-31 |
4 |
D |
$6.72 |
$41,630 |
I/I |
(6,195) |
0 |
0 |
- |
|
| NVET |
Nexvet Biopharma Plc |
Director |
– • – |
2017-07-31 |
4 |
D |
$6.72 |
$72,576 |
D/D |
(10,800) |
0 |
0 |
- |
|
| NVET |
Nexvet Biopharma Plc |
Director |
– • – |
2017-07-01 |
4 |
OE |
$0.13 |
$450 |
D/D |
3,600 |
10,800 |
0 |
- |
|
| NVET |
Nexvet Biopharma Plc |
Director |
– • – |
2016-07-01 |
4/A |
OE |
$0.13 |
$450 |
D/D |
3,600 |
7,200 |
0 |
- |
|
| NVET |
Nexvet Biopharma Plc |
Director |
– • – |
2016-07-01 |
4 |
OE |
$0.13 |
$450 |
D/D |
3,600 |
3,600 |
0 |
- |
|
| NVET |
Nexvet Biopharma Plc |
Director |
– • – |
2015-06-30 |
4 |
OE |
$0.13 |
$113 |
D/D |
900 |
3,600 |
0 |
- |
|
| NVET |
Nexvet Biopharma Plc |
Director |
– • – |
2015-05-18 |
4 |
OE |
$0.13 |
$113 |
D/D |
900 |
2,700 |
0 |
- |
|
| NVET |
Nexvet Biopharma Plc |
Director |
– • – |
2015-02-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,195 |
|
- |
|
| NVET |
Nexvet Biopharma Plc |
Director |
– • – |
2015-02-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,800 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
